Hypersensitivity reactions to cancer chemotherapeutic agents.
Hypersensitivity reactions from cytotoxic agents have not been accorded much attention. Certain drugs (L-asparaginase, cisplatin, intravenous melphalan, topical mechlorethamine, zinostatin, and teniposide) produce reactions often enough to be a clinical problem. Others (cyclophosphamide, doxorubicin, daunorubicin, methotrexate, and procarbazine) do so only occasionally. Bleomycin uniquely produces an occasional hyperpyrexic reaction with clinical findings similar to anaphylaxis. Some cytotoxic agents have never been known to produce hypersensitivity reactions. This paper reviews the frequency and clinical information about such reactions, factors augmenting or decreasing the frequency, and, where possible, the etiologic mechanisms.
D000477:Alkylating Agents / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D004342:Drug Hypersensitivity; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D011034:Podophyllotoxin / Q000009:adverse effects; D011344:Procarbazine / Q000009:adverse effects
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D011344:Procarbazine; D001215:Asparaginase; D011034:Podophyllotoxin; D002945:Cisplatin; D008727:Methotrexate